News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Ex-FDA Head Says Biotech Business Model "Is Basically Falling Apart"



8/26/2014 6:31:49 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

A former head of the U.S. Food and Drug Administration says the agency is holding back, rather than encouraging, the creation of groundbreaking new drugs. Andrew von Eschenbach, commissioner of the FDA for more than two years until January 2009, said in an interview that as a result of FDA demands, drug trials have become too large and expensive. He said the FDA has become too "risk-averse" at a time when scientists in the pharmaceutical industry are moving forward like never before.

Hey, check out all the research scientist jobs. Post your resume today!

Read at News Release


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES